Originally published by our sister publication Pain Medicine News
Patients suffering from opioid use disorder who are treated with methadone in conjunction with conditioned open-label placebo (C-OLP) have better rates of retention in treatment compared with those only taking methadone; however, there was no statistically significant difference in the amount of methadone administered to patients in each group, according to a recent study.
The open-label, single-blind randomized trial occurred